Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine PROMISE-2 (vol 94, pg e1365, 2020)

被引：0
作者：
Lipton
机构：
来源：
NEUROLOGY | 2023年 / 101卷 / 06期
关键词：
D O I：
10.1212/WNL.0000000000207168
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The Research Article "Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2" by Lipton et al.(1) had several minor data errors. The article has been replaced by a corrected version. The original version with the changes highlighted is available from a link in the corrected article. The authors regret the errors.
引用
收藏
页数：2
相关论文
共 1 条
[1]   Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2 [J].
Lipton, Richard B. ;
Goadsby, Peter J. ;
Smith, Jeff ;
Schaeffler, Barbara A. ;
Biondi, David M. ;
Hirman, Joe ;
Pederson, Susan ;
Allan, Brent ;
Cady, Roger .
NEUROLOGY, 2020, 94 (13) :E1365-E1377
1